Literature DB >> 24757294

Inflammatory cytokines, apoptotic, tissue injury and remodeling biomarkers in children with congenital heart disease.

Yasser E Nassef1, Manal A Hamed2, Hanan F Aly2.   

Abstract

The present study aims to evaluate specific biomarkers involved in congenital heart disease (CHD), and whether there is a significant differences between the levels of these biomarkers in the cyanotic CHD (CCHD) and acyanotic CHD (ACHD). We prospectively measured tumor necrosis factor (TNF-α), interleukin-6 (IL-6), C-reactive protein (CRP), vasoendothelial growth factor (VEGF), troponin T, creatin kinase MB (CKMB), and Caspase 3 levels in 120 consecutive children with CHD (60 cyanotic and 60 a cyanotic with age 1:4 years), and 30 healthy control children. Significant elevated levels of inflammatory markers; TNF-α, IL-6 and CRP was detected in CHD, with percentage increase in cyanotic than a cyanotic subjects as compared to the normal one. Apoptotic biomarker; caspase 3 showed also significant increases in CCHD than ACHD. In addition, tissue injury mechanisms included troponin T and CKMB, exhibited significant increase in cyanotic than a cyanotic CHD. The present results demonstrate also, significant enhancement in remodeling process (VEGF), in cyanotic than a cyanotic patients. Thus, it could be concluded that, the children with CCHD were shown to have elevated levels of inflammatory cytokines, caspase 3, troponin T, and CKMB as these biomarkers may implicated in cardiac functional status.

Entities:  

Keywords:  Acyanotic heart disease; Caspase 3; Cyanotic heart disease; IL-6; TNF-α; VEGF

Year:  2013        PMID: 24757294      PMCID: PMC3990814          DOI: 10.1007/s12291-013-0341-0

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  22 in total

Review 1.  Coagulation abnormalities in patients with cyanotic congenital heart disease.

Authors:  Deepak K Tempe; Sanjula Virmani
Journal:  J Cardiothorac Vasc Anesth       Date:  2002-12       Impact factor: 2.628

2.  Tumor necrosis factor-alpha and cardiomyopathy.

Authors:  M R Bristow
Journal:  Circulation       Date:  1998-04-14       Impact factor: 29.690

3.  Preoperative and postoperative endotoxemia in children with congenital heart disease.

Authors:  L L Lequier; H Nikaidoh; S R Leonard; J L Bokovoy; M L White; P J Scannon; B P Giroir
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

4.  The thrombomodulin/protein C/protein S anticoagulant pathway modulates the thrombogenic properties of the normal resting and stimulated endothelium.

Authors:  Y Cadroy; A Diquélou; D Dupouy; J P Bossavy; K S Sakariassen; P Sié; B Boneu
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-03       Impact factor: 8.311

5.  Cyanotic congenital heart disease and coronary artery atherogenesis.

Authors:  Alistair Fyfe; Joseph K Perloff; Koichiro Niwa; John S Child; Pamela D Miner
Journal:  Am J Cardiol       Date:  2005-07-15       Impact factor: 2.778

6.  Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

Authors:  J Niebauer; H D Volk; M Kemp; M Dominguez; R R Schumann; M Rauchhaus; P A Poole-Wilson; A J Coats; S D Anker
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

7.  Plasma nitric oxide products correlate with cardiac index of congenital heart disease.

Authors:  J Takaya; Y Ikemoto; M Teraguchi; S Nogi; Y Kobayashi
Journal:  Pediatr Cardiol       Date:  2000 Jul-Aug       Impact factor: 1.655

8.  Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients.

Authors:  O A Paniagua; M B Bryant; J A Panza
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

Review 9.  Apoptosis. Basic concepts and implications in coronary artery disease.

Authors:  P J Best; D Hasdai; G Sangiorgi; R S Schwartz; D R Holmes; R D Simari; A Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-01       Impact factor: 8.311

10.  Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.

Authors:  I Adatia; S E Barrow; P Stratton; J M Ritter; S G Haworth
Journal:  Br Heart J       Date:  1993-02
View more
  4 in total

Review 1.  Elevated serum levels of ghrelin and TNF-α in patients with cyanotic and acyanotic congenital heart disease.

Authors:  Sai Zhang; Gong-Liang Guo; Li-Li Yang; Li-Qun Sun
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

2.  Effect of ketamine on pro- and anti-inflammatory cytokine response in paediatric cardiac surgery: A prospective randomised controlled study.

Authors:  Tamer Hamed Ibrahim; Hassan Saad Abdelrahman; Mohammed A Alharbi; Ibrahim A Zabani; Mohamed Fouad Ismail; Heba Kary
Journal:  Indian J Anaesth       Date:  2017-07

3.  Significant Modules and Biological Processes between Active Components of Salvia miltiorrhiza Depside Salt and Aspirin.

Authors:  Yuan Li; Yanming Xie; Lianxin Wang; Yingying Zhang; Hao Gu; Yan Chai
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-16       Impact factor: 2.629

4.  Myocardial Injury in Children with Unoperated Congenital Heart Diseases.

Authors:  Mohamed O Hafez; Saed M Morsy; Ragab A Mahfoz; Ahmed R Ali
Journal:  Cardiol Res Pract       Date:  2015-11-16       Impact factor: 1.866

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.